September 21, 2017 — MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 ...
Cardiovascular Clinical Studies
This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.
September 21, 2017
September 20, 2017 — Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the ...
September 20, 2017
September 18, 2017 — Corindus Vascular Robotics Inc. announced first patient enrollment in the PRECISION GRX Registry, a ...
September 18, 2017
September 18, 2017 — Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU ...
September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the Journal of the American College of ...
September 18, 2017
September 14, 2017 — Marijuana use is associated with a three-fold risk of death from hypertension, according to ...
September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...
September 14, 2017
September 13, 2017 — Medtronic plc announced that the In.Pact Admiral Drug-Coated Balloon (DCB) received approval from ...
September 13, 2017
PQ Bypass Reports Positive Results for Detour System in Patients With Long Femoropopliteal Blockages
September 13, 2017 — A subset analysis of the DETOUR I clinical trial showed promising safety and effectiveness results ...
September 13, 2017September 12, 2017 — Contracting shingles, a reactivation of the chickenpox virus, increases a person’s risk of stroke a ...
September 12, 2017
September 12, 2017 — A new screening program for vascular disease saves one life for every 169 men assessed, according ...
September 12, 2017September 12, 2017 — Inclisiran lowers low-density lipoprotein (LDL, or “bad”) cholesterol for up to one year in ...
September 12, 2017
September 12, 2017 — Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017
September 12, 2017 — The IL-1β inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...
September 12, 2017
September 12, 2017 — Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
September 12, 2017